NEW
YORK, Dec. 23, 2024 /PRNewswire/ -- The Gross
Law Firm issues the following notice to shareholders of Cassava
Sciences, Inc. (NASDAQ: SAVA).
Shareholders who purchased shares of SAVA during the class
period listed are encouraged to contact the firm regarding possible
lead plaintiff appointment. Appointment as lead plaintiff is not
required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/cassava-sciences-inc-loss-submission-form-2/?id=117775&from=4
CLASS PERIOD: February 7,
2024 to November 24, 2024
ALLEGATIONS: According to the complaint, defendants
provided investors with material information concerning Cassava's
leading drug candidate, simufilam. Defendants' statements included,
among other things, clear confidence in simufilam's ability to
treat Alzheimer's Disease. On November 25,
2024, Cassava released topline results for the first of its
two ongoing Phase 3 studies on simufilam, the "ReThink-ALZ"
study. The results indicated that simufilam failed to meet
each of the pre-specified primary, secondary, and exploratory
endpoints; in sum, simufilam failed to outperform the
placebo. Following this news, the price of Cassava's
common stock declined dramatically. From a closing market price of
$26.48 per share on November 22, 2024, Cassava's stock price fell to
$4.30 per share on November 25, 2024, a decline of about 83.76% in
the span of just a single day.
DEADLINE: February 10, 2025
Shareholders should not delay in registering for this class action.
Register your information here:
https://securitiesclasslaw.com/securities/cassava-sciences-inc-loss-submission-form-2/?id=117775&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a
shareholder who purchased shares of SAVA during the timeframe
listed above, you will be enrolled in a portfolio monitoring
software to provide you with status updates throughout the
lifecycle of the case. The deadline to seek to be a lead plaintiff
is February 10, 2025. There is no
cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross Law
Firm is committed to ensuring that companies adhere to responsible
business practices and engage in good corporate citizenship. The
firm seeks recovery on behalf of investors who incurred losses when
false and/or misleading statements or the omission of material
information by a company lead to artificial inflation of the
company's stock. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content to download
multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-february-10-2025-in-cassava-sciences-inc-lawsuit--sava-302337831.html
SOURCE The Gross Law Firm
